Original ArticlesHigh Incidence of Somatic BAP1 Alterations in Sporadic Malignant Mesothelioma
Key Words
Cited by (0)
Disclosures: Dr. Carbone was supported by National Institute of Health (grant numbers R01CA106567, P01CA114047, P30CA071789) and by the University of Hawai'i Foundation, which received donations to support mesothelioma research from Honeywell International Inc. Dr. Yang was supported by National Institute of Health (R01CA160715-0A) and received the DoD CDMRP PRCRP Career Development Award. Dr. Yang was supported by the Mesothelioma Applied Research Foundation, the United-4 A Cure, the Hawai'i Community Foundation. Dr. Carbone and Dr. Yang were supported by the V Foundation, the P30CA071789 (UHCC Pathology Shared Resource and UHCC GSR). Dr. Becich and Dr. Pass were supported by the National Mesothelioma Virtual Bank, CDC NIOSH 2U24-OH009077-08. Dr. Carbone has pending patent applications on BAP1, and both Dr. Carbone and Dr. Gazdar provide consultation for mesothelioma expertise and diagnosis. All other authors declare no conflict of interest.